Nouveau profil
La refonte en profondeur de Bourrelier Group suite à la cession de l’essentiel de ses actifs opérationnels est désormais prise en compte après publication des comptes 2017 décalés sur l’été…
H1 18: insignificant; some more time needed to reach the market
Crossject released its H1 18 results. Revenues reached €2,840k (vs €1,635k), operating result €-5,337k (vs €-4,256k), and the net result €-4,744k (vs €-3,360k). Net cash at the end of H1…
Robust earnings delivery in more choppy (FX)) waters
H1 18 earnings do confirm the ability of Chargeurs’ management to deliver in more adverse FX conditions and to stick to its quality growth promises. The up and coming group…
The market is within reach
We have fine-tuned our numbers on the back of the group’s latest comments as well as integrating the new NTE (New Therapeutic Entity) to be developed (Terbutaline), instead of Apomorphine…
A convertible bond and potential options for existing shareholders
Crossject announced the principle of granting of free options (“BSA”) to existing shareholders (to compensate for the fact the ones granted in February could not be exercised) as well as…
One stone, many great birds
Chargeurs’ first significant acquisition looks to tick all the right boxes: strategically perfect, better use of capital and giving a fresh twist to its hitherto low growth business, Fashion Technologies….
Business update
Crossject has published a short release to comment on its activities. As we expected, the group confirmed the planning of market approval filings in Europe and the US (FY19 for…
Strong divisional contributions partly absorbed by financing costs
EPS adjustments are essentially the by-product of 2017 final numbers highlighting rising central costs and a higher than expected interest bill (excess resources). This new base as well as an…
Transition year is behind, brighter outlook
After a difficult year of transition for Keyware, which was mainly seen through the Payment Terminal (PT) division’s lower revenues and profitability, we have decreased our earnings forecasts for the…
On its way to reach the market…
Crossject released its FY17 results. Revenues came in at €4.14m vs €1.43m, operating result €-8,621k (vs €-7,291k), and net result €-7,611k (vs €-6,663k). Net cash at the end of FY17…